首页 | 本学科首页   官方微博 | 高级检索  
     


AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
Authors:Todd M. Cooper DO  Todd A. Alonzo PhD  Robert B. Gerbing MA  John P. Perentesis MD  James A. Whitlock MD  Jeffrey W. Taub MD  Terzah M. Horton MD  Alan S. Gamis MD  MPH  Soheil Meshinchi MD  PhD  Michael R. Loken PhD  Bassem I. Razzouk MD
Affiliation:1. Pediatric Hematology/Oncology, Aflac Cancer Center and Blood Disorders Service, Emory University, Atlanta, Georgia;2. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California;3. Children's Oncology Group, Arcadia, California;4. Division of Oncology and Cancer Programs, Cincinnati Children's Medical Center, Cincinnati, Ohio;5. Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada;6. Division of Oncology, Department of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan;7. Department of Pediatrics‐Hematology and Oncology, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas;8. Pediatric Hematology/Oncology, Children's Mercy Hospitals and Clinics, Kansas City, Missouri;9. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington;10. HematoLogics Inc, Seattle, Washington;11. Peyton Manning Children's Hospital at St. Vincent, Indianapolis, Indiana
Abstract:
Keywords:clofarabine  cytarabine  acute myeloid leukemia  pediatric
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号